Mycomed Technologies LLC

Mycomed Technologies LLC, based in Baltimore, MD, is pioneering advancements in the diagnosis of lung infections through its innovative in vitro diagnostics. The company focuses on the identification of circulating microbial extracellular vesicles, enhancing the early detection of lung infections via urine samples.

Through its product line, Pearl Diagnostics, the company has developed novel diagnostic assays aimed at improving clinical outcomes for patients with lung infections. These cutting-edge solutions are not yet available in the United States, reflecting the company's commitment to research and development in the field of diagnostics.

Generated from the website